Core Viewpoint - The company plans to acquire 97.4399% of Hangzhou Lipo Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds through share issuance to related parties [1][2] Group 1: Transaction Details - The company intends to purchase shares from 14 counterparties, including Wang Xulongqi and Deng Haoyu [1] - The board meetings on March 6, August 6, and the extraordinary shareholders' meeting on August 22, 2025, approved the relevant proposals for this transaction [1] - The transaction requires approvals from the Shanghai Stock Exchange and the China Securities Regulatory Commission, among other regulatory bodies [3] Group 2: Change of Review Agency - The company replaced Yongtuo Accounting Firm with Tianjian Accounting Firm as the preparatory review agency for the transaction due to the former's inability to complete the work on time [2] - Tianjian Accounting Firm has completed the review work and issued a report as of May 31, 2025 [2] - The board meeting on August 26, 2025, approved the change of the review agency and related documents [2]
狮头股份: 关于变更发行股份及支付现金购买资产并募集配套资金暨关联交易备考审阅机构的公告